Joseph J. Allen, OD, FAAO, Dipl ABO
Show Description +
Curious about prescribing cenegermin-bkbj (Oxervate, Dompé) for patients with neurotrophic keratitis? Joseph Allen, OD, FAAO, Dipl ABO, explains how to do just that, plus he shares insights into the patient experience, which are unique to this particular drug, and he reviews what the clinical trial data have shown about Oxervate’s efficacy and side effects.
Posted: 12/08/2022
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Justin Manning, OD, MPH, FAAO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Harbir Sian, OD
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO; and Jessilin Quint, OD, MS, MBA, FAAO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Rachael Wruble, OD, FAAO
Joseph J. Allen, OD, FAAO, Dipl ABO; and Will To, OD, ABOC
Joseph J. Allen, OD, FAAO, Dipl ABO; and Trevor Fosso, OD, FAAO, FSCS
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Laura M. Periman, MD; and Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Joseph J. Allen, OD, FAAO
Jaclyn Garlich, OD, FAAO; and Joseph J. Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO, Saleel Jivraj, OD, MBA, FAAO, FCOptom, FBCLA
Darryl Glover, OD, Joseph Allen, OD, FAAO
Jennifer Lyerly, OD, Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO, Solomon Gould, OD, MBA
Joseph Allen, OD, FAAO, Solomon Gould, OD, MBA
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO; Cecelia Koetting, OD, FAAO, Dipl ABO; Jacqueline Theis, OD, FAAO, FNAP; and Jade Coats, OD
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Joseph Allen, OD, FAAO, Dipl ABO
Joseph J. Allen, OD, FAAO, Dipl ABO
Curious about prescribing cenegermin-bkbj (Oxervate, Dompé) for patients with neurotrophic keratitis? Joseph Allen, OD, FAAO, Dipl ABO, explains how to do just that, plus he shares insights into the patient experience, which are unique to this particular drug, and he reviews what the clinical trial data have shown about Oxervate’s efficacy and side effects.
Posted: 12/08/2022
Ozana Moraru, MD
Alan Carlson, MD
Aaron T. Gomez, BS, Majid Moshirfar MD, Orry Birdsong, MD
Please log in to leave a comment.